UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis
USA - NYSE:UHS - US9139031002 - Common Stock
188.82 USD
+0.71 (+0.38%)
We assign a fundamental rating of 6 out of 10 to UHS. UHS was compared to 101 industry peers in the Health Care Providers & Services industry. While UHS has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on UHS. This makes UHS very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year UHS was profitable.
UHS had a positive operating cash flow in the past year.
In the past 5 years UHS has always been profitable.
UHS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.41%, UHS belongs to the top of the industry, outperforming 92.08% of the companies in the same industry.
UHS has a better Return On Equity (17.94%) than 86.14% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.02%, UHS belongs to the top of the industry, outperforming 84.16% of the companies in the same industry.
UHS had an Average Return On Invested Capital over the past 3 years of 8.28%. This is in line with the industry average of 9.19%.
The 3 year average ROIC (8.28%) for UHS is below the current ROIC(11.02%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.41% | ||
| ROE | 17.94% | ||
| ROIC | 11.02% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
1.3 Margins
With an excellent Profit Margin value of 7.66%, UHS belongs to the best of the industry, outperforming 89.11% of the companies in the same industry.
UHS's Profit Margin has been stable in the last couple of years.
UHS has a better Operating Margin (11.01%) than 82.18% of its industry peers.
UHS's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.01% | ||
| PM (TTM) | 7.66% | ||
| GM | N/A |
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UHS is creating some value.
The number of shares outstanding for UHS has been reduced compared to 1 year ago.
Compared to 5 years ago, UHS has less shares outstanding
Compared to 1 year ago, UHS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.11 indicates that UHS is not in any danger for bankruptcy at the moment.
UHS has a better Altman-Z score (3.11) than 62.38% of its industry peers.
The Debt to FCF ratio of UHS is 5.08, which is a neutral value as it means it would take UHS, 5.08 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.08, UHS is doing good in the industry, outperforming 68.32% of the companies in the same industry.
A Debt/Equity ratio of 0.65 indicates that UHS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.65, UHS perfoms like the industry average, outperforming 55.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.08 | ||
| Altman-Z | 3.11 |
ROIC/WACC1.38
WACC7.97%
2.3 Liquidity
A Current Ratio of 1.29 indicates that UHS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.29, UHS perfoms like the industry average, outperforming 40.59% of the companies in the same industry.
A Quick Ratio of 1.19 indicates that UHS should not have too much problems paying its short term obligations.
UHS's Quick ratio of 1.19 is in line compared to the rest of the industry. UHS outperforms 43.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.47%, which is quite impressive.
The Earnings Per Share has been growing by 10.74% on average over the past years. This is quite good.
Looking at the last year, UHS shows a quite strong growth in Revenue. The Revenue has grown by 9.61% in the last year.
The Revenue has been growing slightly by 6.82% on average over the past years.
EPS 1Y (TTM)37.47%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%24.13%
Revenue 1Y (TTM)9.61%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%9.63%
3.2 Future
Based on estimates for the next years, UHS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.65% on average per year.
UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.70% yearly.
EPS Next Y24.6%
EPS Next 2Y15.2%
EPS Next 3Y13.49%
EPS Next 5Y11.65%
Revenue Next Year9.3%
Revenue Next 2Y7.09%
Revenue Next 3Y6.45%
Revenue Next 5Y4.7%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.03, the valuation of UHS can be described as very reasonable.
91.09% of the companies in the same industry are more expensive than UHS, based on the Price/Earnings ratio.
UHS is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.55, the valuation of UHS can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 93.07% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of UHS to the average of the S&P500 Index (22.88), we can say UHS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.03 | ||
| Fwd PE | 8.55 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UHS is valued cheaper than 86.14% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UHS is valued cheaply inside the industry as 80.20% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.33 | ||
| EV/EBITDA | 6.82 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of UHS may justify a higher PE ratio.
A more expensive valuation may be justified as UHS's earnings are expected to grow with 13.49% in the coming years.
PEG (NY)0.41
PEG (5Y)0.93
EPS Next 2Y15.2%
EPS Next 3Y13.49%
5. Dividend
5.1 Amount
UHS has a yearly dividend return of 0.42%, which is pretty low.
Compared to an average industry Dividend Yield of 2.43, UHS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, UHS's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
5.2 History
The dividend of UHS is nicely growing with an annual growth rate of 6.27%!
UHS has paid a dividend for at least 10 years, which is a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
UHS pays out 4.19% of its income as dividend. This is a sustainable payout ratio.
The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP4.19%
EPS Next 2Y15.2%
EPS Next 3Y13.49%
NYSE:UHS (9/19/2025, 3:16:47 PM)
188.82
+0.71 (+0.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.55%
Inst Owner Change-1.18%
Ins Owners4.77%
Ins Owner Change16.93%
Market Cap12.02B
Analysts69.23
Price Target222.55 (17.86%)
Short Float %4.5%
Short Ratio2.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP4.19%
Div Incr Years0
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.89%
Min EPS beat(2)7.62%
Max EPS beat(2)10.15%
EPS beat(4)4
Avg EPS beat(4)8.74%
Min EPS beat(4)0.53%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)11.9%
EPS beat(12)12
Avg EPS beat(12)9.02%
EPS beat(16)13
Avg EPS beat(16)5.35%
Revenue beat(2)1
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-2.29%
Max Revenue beat(2)0.18%
Revenue beat(4)3
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)1.57%
Revenue beat(8)6
Avg Revenue beat(8)0.11%
Revenue beat(12)9
Avg Revenue beat(12)0.14%
Revenue beat(16)13
Avg Revenue beat(16)0.46%
PT rev (1m)-1.33%
PT rev (3m)-2.88%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)4.77%
EPS NY rev (1m)4.31%
EPS NY rev (3m)4.32%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.21%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.03 | ||
| Fwd PE | 8.55 | ||
| P/S | 0.73 | ||
| P/FCF | 13.33 | ||
| P/OCF | 6.32 | ||
| P/B | 1.71 | ||
| P/tB | 3.94 | ||
| EV/EBITDA | 6.82 |
EPS(TTM)18.82
EY9.97%
EPS(NY)22.08
Fwd EY11.7%
FCF(TTM)14.17
FCFY7.5%
OCF(TTM)29.86
OCFY15.82%
SpS258.65
BVpS110.47
TBVpS47.96
PEG (NY)0.41
PEG (5Y)0.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.41% | ||
| ROE | 17.94% | ||
| ROCE | 14.3% | ||
| ROIC | 11.02% | ||
| ROICexc | 11.14% | ||
| ROICexgc | 16.33% | ||
| OM | 11.01% | ||
| PM (TTM) | 7.66% | ||
| GM | N/A | ||
| FCFM | 5.48% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexcg growth 3Y1.9%
ROICexcg growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.08 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 167.41% | ||
| Cap/Sales | 6.07% | ||
| Interest Coverage | 12.09 | ||
| Cash Conversion | 78.91% | ||
| Profit Quality | 71.49% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 3.11 |
F-Score9
WACC7.97%
ROIC/WACC1.38
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)37.47%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%24.13%
EPS Next Y24.6%
EPS Next 2Y15.2%
EPS Next 3Y13.49%
EPS Next 5Y11.65%
Revenue 1Y (TTM)9.61%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%9.63%
Revenue Next Year9.3%
Revenue Next 2Y7.09%
Revenue Next 3Y6.45%
Revenue Next 5Y4.7%
EBIT growth 1Y25.67%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year54.97%
EBIT Next 3Y19.45%
EBIT Next 5YN/A
FCF growth 1Y77.13%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y62.2%
OCF growth 3Y32.75%
OCF growth 5Y7.52%